Foster Dykema Cabot & Partners, LLC Roivant Sciences Ltd. Call Options Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
319Shares Held
524MCall Options Held
1.3MPut Options Held
1.09M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$788 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$786 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$646 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$498 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$423 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.42B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...